# Isomorphic Labs raises USD 2.1 billion Series B

On 2026/5/12, X reported that UK AI drug discovery company Isomorphic Labs, led by Demis Hassabis, had raised USD 2.1 billion in Series B funding to shorten drug development cycles.



Canonical: https://uniquebase.ai/news/a603275b-b9f4-47f9-aa0d-886fb20aedac
Stable identifier: a603275b-b9f4-47f9-aa0d-886fb20aedac
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T23:49:37.335Z

## Connected profiles

- [Alphabet](/institutions/alphabet)
- [CapitalG](/institutions/capitalg)
- [Danmaxi](/institutions/danmaxi)
- [Isomorphic Labs](/companies/isomorphic-labs)
- [MGX](/institutions/mgx)
- [Thrive Capital](/institutions/thrive-capital)

## Sources

- https://x.com/AYi_AInotes/status/2054227787536289941